Production, characterization, and epitope mapping of monoclonal antibodies of ribosomal protein S3 (rpS3)

References

• Aggarwal S. 2009. What's fueling the biotech engine. 2008. Nature Biotechnol. 27:987–993.
   PubMed Web of Science ®Google Scholar
• Banik S, Deng X, Doranz B. 2017. Using epitope mapping to derive more value from mAbs. Gen Eng Biotechnol News. 37(15).
   Google Scholar
• Beck A, Reichert JM, Wurch T. 2010. 5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland. MAbs. 2(2):108–128.
   PubMedGoogle Scholar
• Beck A, Wurch T, Corvaïa N. 2008. Therapeutic antibodies and derivatives: from the bench to the clinic. Curr Pharm Biotechnol. 9(6):421–422.
   PubMed Web of Science ®Google Scholar
• Beckman RA, Weiner LM, Davis HM. 2007. Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors. Cancer. 109(2):170–179.
   PubMed Web of Science ®Google Scholar
• Burrin J, Newman D. 1991. Production and assessment of antibodies. In: Price CP, Newman DJ, editors. Principles and practice of immunoassay. London: Palgrave Macmillan.
   Google Scholar
• Bush S. 2002. Monoclonal antibodies conjugated with radioisotopes for the treatment of Non-Hodgkin's lymphoma. Semin Oncol Nurs. 18(1 Suppl 1):16–21.
   PubMedGoogle Scholar
• Carter P. 2001. Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer. 1(2):118–129.
   PubMed Web of Science ®Google Scholar
• Davidson E, Bryan C, Fong RH, Barnes T, Pfaff JM, Mabila M, Rucker JB, Doranz BJ. 2015. Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies. J Virol. 89(21):10982–10992.
   PubMed Web of Science ®Google Scholar
• Davidson E, Doranz BJ. 2014. A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes. Immunology. 143(1):13–20.
   PubMed Web of Science ®Google Scholar
• Dejana E, Corada M. 1999. Adhesion protein protocols. Springer Science & Business Media.
   Google Scholar
• DeLisser HM. 1999. Epitope mapping. Adhesion protein protocols. Methods Mol Biol. 96:11–20.
   PubMedGoogle Scholar
• Deng X, Storz U, Doranz BJ. 2018. Enhancing antibody patent protection using epitope mapping information. MAbs. 10(2):204–209.
   PubMed Web of Science ®Google Scholar
• Desterro JM, Rodriguez MS, Hay RT. 1998. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell. 2(2):233–239.
   PubMed Web of Science ®Google Scholar
• Dutton G. 2016. Integral molecular sizes up Ebola: membrane protein specialist maps Ebola's binding sites to advance vaccine discovery. Gen Eng Biotechnol News. 36(1):8–9.
   Google Scholar
• Flinn IW, Lazarus HM. 2001. Monoclonal antibodies and autologous stem cell transplantation for lymphoma. Bone Marrow Transpl. 27(6):565–569.
   PubMed Web of Science ®Google Scholar
• Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski Freund N, Weiss Y. 2007. Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs. 21(3):145–156.
   PubMed Web of Science ®Google Scholar
• Geysen HM, Meloen RH, Barteling SJ. 1984. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. PNAS. 81(13):3998–4002.
   PubMed Web of Science ®Google Scholar
• Hanack K, Messerschmidt K, Listek M. 2016. Antibodies and selection of monoclonal antibodies. Adv Exp Med Biol. 917:11–22.
   PubMedGoogle Scholar
• Hansen LB, Buus S, Schafer-Nielsen C. 2013. Identification and mapping of linear antibody epitopes in human serum albumin using high-density peptide arrays. PLoS One. 8(7):e68902.
   PubMed Web of Science ®Google Scholar
• Hegde V, Wang M, Deutsch WA. 2004. Human ribosomal protein S3 interacts with DNA base excision repair proteins hAPE/Ref-1 and hOGG1. Biochemistry. 43(44):14211–14217.
   PubMed Web of Science ®Google Scholar
• Jang HS, Kim K, Lee MR, Kim SH, Choi JH, Park MJ. 2020. Treatment of growth hormone attenuates hepatic steatosis in hyperlipidemic mice via downregulation of hepatic CD36 expression. Anim Cells Syst (Seoul). 2020 Jun 12;24(3):151–159.
   PubMed Web of Science ®Google Scholar
• Kim HD, Kim TS, Joo YJ, Shin HS, Kim SH, Jang CY, Lee CE, Kim J. 2010. Rps3 translation is repressed by interaction with its own mRNA. J Cell Biochem. 110(2):294–303.
   PubMed Web of Science ®Google Scholar
• Kim J, Chubatsu LS, Admon A, Stahl J, Fellous R, Linn S. 1995. Implication of mammalian ribosomal protein S3 in the processing of DNA damage. J Biol Chem. 270(23):13620–13629.
   PubMed Web of Science ®Google Scholar
• Kim J, Linn S. 1989. Purification and characterization of UV endonucleases I and II from murine plasmacytoma cells. J Biol Chem. 264(5):2739–2745.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JY, Kim J. 2005. Characterization of a wide range base-damage-endonuclease activity of mammalian rpS3. Biochem Biophys Res Commun. 328(4):962–967.
   PubMed Web of Science ®Google Scholar
• Kim Y, Kim HD, Kim J. 2013. Cytoplasmic ribosomal protein S3 (rpS3) plays a pivotal role in mitochondrial DNA damage surveillance. Biochim Biophys Acta. 1833(12):2943–2952.
   PubMed Web of Science ®Google Scholar
• Kim Y, Lee MS, Kim HD, Kim J. 2016. Ribosomal protein S3 (rpS3) secreted from various cancer cells is N-linked glycosylated. Oncotarget. 7(49):80350–80362.
   PubMedGoogle Scholar
• Ladner RC. 2007. Mapping the epitopes of antibodies. Biotechnol Genet Eng Rev. 24:1–30.
   PubMedGoogle Scholar
• Leclair P, Lim CJ. 2020. CD47 (Cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions. Anim Cells Syst (Seoul). 24(5):243–252.
   PubMed Web of Science ®Google Scholar
• Ledford H. 2018. Rush to protect lucrative antibody patents kicks into gear. Nature. 557(7706):623–625.
   PubMedGoogle Scholar
• Lee SM, Kim M, Moon EP, Lee BJ, Choi JY, Kim J. 2006. Genomic structure and transcriptional studies on the mouse ribosomal protein S3 gene: expression of U15 small nucleolar RNA. Gene. 368:12–20.
   PubMed Web of Science ®Google Scholar
• Lim Y, Lee SM, Kim M, Lee JY, Moon EP, Lee BJ, Kim J. 2002. Complete genomic structure of human rpS3: identification of functional U15b snoRNA in the fifth intron. Gene. 286(2):291–297.
   PubMed Web of Science ®Google Scholar
• Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC. 2020. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 27(1):1.
   PubMed Web of Science ®Google Scholar
• Maleki LA, Baradaran B, Majidi J, Mohammadian M, Shahneh FZ. 2013. Future prospects of monoclonal antibodies as magic bullets in immunotherapy. Hum Antibodies. 22(1-2):9–13.
   PubMedGoogle Scholar
• Malito E, Biancucci M, Faleri A, Ferlenghi I, Scarselli M, Maruggi G, et al. 2014. Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody. PNAS. 111(48):17128–17133.
   PubMed Web of Science ®Google Scholar
• Malito E, Faleri A, Lo Surdo P, Veggi D, Maruggi G, Grassi E, et al. 2013. Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. PNAS. 110(9):3304–3309.
   PubMed Web of Science ®Google Scholar
• Nelson PN, Reynolds GM, Waldron EE, Ward E, Giannopoulos K, Murray PG. 2000. Monoclonal antibodies. Mol Pathol. 53:111–117.
   PubMedGoogle Scholar
• Park HJ, Jang GY, Kim YS, Park JH, Lee SE, Vo MC, Lee JJ, Han HD, Jung ID, Kang TH, Park YM. 2019. A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine. J Immunother Cancer. 7(1):60.
   PubMedGoogle Scholar
• Park YJ, Kim EH, Kim TS, Kim HD, Kim J. 2020. Ribosomal protein S3 is a novel negative regulator of non-homologous end joining repair of DNA double-strand breaks. FASEB J. 34(6):8102–8113.
   PubMed Web of Science ®Google Scholar
• Park YJ, Kim SH, Kim TS, Lee SM, Cho BS, Seo CI, Kim HD, Kim J. 2021. Ribosomal protein S3 associates with the TFIIH complex and positively regulates nucleotide excision repair. Cell Mol Life Sci. 78(7):3591–3606.
   PubMed Web of Science ®Google Scholar
• Pogue-Geile K, Geiser JR, Shu M, Miller C, Wool IG, Meisler AI, Pipas JM. 1991. Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol. 11(8):3842–3849.
   PubMed Web of Science ®Google Scholar
• Polakiewicz RD, Munroe DJ, Sait SN, Tycowski KT, Nowak NJ, Shows TB, Housman DE, Page DC. 1995. Mapping of ribosomal protein S3 and internally nested snoRNA U15A gene to human chromosome 11q13.3-q13.5. Genomics. 25(2):577–580.
   PubMed Web of Science ®Google Scholar
• Potocnakova L, Bhide M, Pulzova LB. 2016. An introduction to B-cell epitope mapping and in silico epitope prediction. J Immunol Res. 2016:6760830.
   PubMed Web of Science ®Google Scholar
• Reichert JM. 2010. Antibodies to watch in 2010. MAbs. 2(1):84–100.
   PubMed Web of Science ®Google Scholar
• Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, et al. 2018. Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection. Cell. 174(4):P938–P952.
   PubMed Web of Science ®Google Scholar
• Schreterova E, Bhide M, Potocnakova L, Borszekova Pulzova L. 2017. Design, construction and evaluation of multi-epitope antigens for diagnosis of Lyme disease. Ann Agric Environ Med. 24(4):696–701.
   PubMed Web of Science ®Google Scholar
• Shakil T, Richardson MK, Waldron E, Condé G, Wood S, Bland Y, Reynolds G, Murray PG, Nelson PN. 2001. Generation and characterization of monoclonal antibodies to the neural crest. Hybridoma. 20:199–203.
   PubMedGoogle Scholar
• Sun L, Lu X, Li C, Wang M, Liu Q, Li Z, Hu X, Li J, Liu F, Li Q, et al. 2009. Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses. PLoS One. 4(5):e5476.
   PubMed Web of Science ®Google Scholar
• Tomita M, Tsumoto K. 2011. Hybridoma technologies for antibody production. Immunotherapy. 3(3):371–380.
   PubMed Web of Science ®Google Scholar
• Webster AC, Pankhurst T, Rinaldi F, Chapman JR, Craig JC. 2006. Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation. 81(7):953–965.
   PubMed Web of Science ®Google Scholar
• Webster AC, Wu S, Tallapragada K, Park MY, Chapman JR, Carr SJ. 2017. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. Cochrane Database Syst Rev. 7(7):CD004756.
   PubMedGoogle Scholar
• Weiner LM, Dhodapkar MV, Ferrone S. 2009. Monoclonal antibodies for cancer immunotherapy. Lancet. 373(9668):1033–1040.
   PubMed Web of Science ®Google Scholar
• Westermann P, Heumann W, Bommer UA, Bielka H, Nygard O, Hultin T. 1979. Crosslinking of initiation factor eIF-2 to proteins of the small subunit of rat liver ribosomes. FEBS Lett. 97(1):101–104.
   PubMed Web of Science ®Google Scholar
• Westwood OM, Hay FC2001. Epitope mapping: a practical approach. Oxford: Oxford University Press.
   Google Scholar
• Yang HW, Kim HD, Kim J. 2019. The DNA repair domain of human rpS3 protects against photoaging by removing cyclobutane pyrimidine dimers. FEBS Lett. 593(15):2060–2068.
   PubMed Web of Science ®Google Scholar
• Zahavi D, Weiner L. 2020. Monoclonal antibodies in cancer therapy. Antibodies (Basel). 9(3):34.
   PubMedGoogle Scholar
• Zhang C. 2012. Hybridoma technology for the generation of monoclonal antibodies. Methods Mol Biol. 901:117–135.
   PubMedGoogle Scholar